Bernhard Kreymann

3.0k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

Bernhard Kreymann is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Bernhard Kreymann has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Bernhard Kreymann's work include Liver Disease and Transplantation (8 papers), Diabetes Treatment and Management (6 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Bernhard Kreymann is often cited by papers focused on Liver Disease and Transplantation (8 papers), Diabetes Treatment and Management (6 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Bernhard Kreymann collaborates with scholars based in Germany, United Kingdom and United States. Bernhard Kreymann's co-authors include Stephen R. Bloom, Mohammad A. Ghatei, Gareth Williams, Sandip M. Kanse, U. Schweigart, Markus Seige, Meinhard Classen, Uwe Heemann, George Nikou and Domhnall O’Halloran and has published in prestigious journals such as The Lancet, Brain Research and FEBS Letters.

In The Last Decade

Bernhard Kreymann

21 papers receiving 2.2k citations

Hit Papers

GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN... 1987 2026 2000 2013 1987 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard Kreymann Germany 14 1.4k 927 478 393 388 23 2.3k
Jean‐Pierre Gutzwiller Switzerland 17 1.1k 0.8× 637 0.7× 398 0.8× 609 1.5× 545 1.4× 27 2.2k
Dana K. Andersen United States 23 1.3k 1.0× 1.2k 1.3× 830 1.7× 183 0.5× 781 2.0× 52 2.8k
Adriana C. C. Girardi Brazil 29 1.4k 1.1× 622 0.7× 1.1k 2.3× 69 0.2× 267 0.7× 92 2.6k
L. Stimmler United Kingdom 22 972 0.7× 558 0.6× 426 0.9× 209 0.5× 385 1.0× 54 2.1k
J Robillard United States 32 652 0.5× 282 0.3× 894 1.9× 326 0.8× 308 0.8× 153 3.2k
Hideo Manaka Japan 20 1.1k 0.8× 370 0.4× 637 1.3× 125 0.3× 359 0.9× 55 2.1k
Takeshi Kurose Japan 27 1.2k 0.9× 685 0.7× 801 1.7× 164 0.4× 374 1.0× 76 2.1k
L. Groop Sweden 30 1.3k 1.0× 873 0.9× 1.1k 2.4× 306 0.8× 1.1k 2.9× 57 3.5k
Gabriele E. Sonnenberg United States 26 835 0.6× 567 0.6× 473 1.0× 555 1.4× 1.1k 2.8× 60 2.8k
Pauli Karhapää Finland 26 853 0.6× 433 0.5× 328 0.7× 293 0.7× 477 1.2× 38 2.1k

Countries citing papers authored by Bernhard Kreymann

Since Specialization
Citations

This map shows the geographic impact of Bernhard Kreymann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Kreymann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Kreymann more than expected).

Fields of papers citing papers by Bernhard Kreymann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Kreymann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Kreymann. The network helps show where Bernhard Kreymann may publish in the future.

Co-authorship network of co-authors of Bernhard Kreymann

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Kreymann. A scholar is included among the top collaborators of Bernhard Kreymann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Kreymann. Bernhard Kreymann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garibay, Aritz Pérez Ruiz de, et al.. (2019). Respiratory and metabolic acidosis correction with the ADVanced Organ Support system. Intensive Care Medicine Experimental. 7(1). 56–56. 16 indexed citations
2.
Matevossian, Edouard, et al.. (2017). Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia. Intensive Care Medicine Experimental. 5(1). 31–31. 9 indexed citations
3.
Salmhofer, Hermann, Michael D. Franzen, Wolfgang Hitzl, et al.. (2013). Multi-Modal Treatment Of Calciphylaxis With Sodium-Thiosulfate, Cinacalcet And Sevelamer Including Long-Term Data. Kidney & Blood Pressure Research. 37(4-5). 346–359. 29 indexed citations
4.
Matevossian, Edouard, Peter B. Luppa, Tibor Schuster, et al.. (2013). Evaluation of the Hepa Wash®treatment in pigs with acute liver failure. BMC Gastroenterology. 13(1). 83–83. 27 indexed citations
5.
Yang, Zhen, et al.. (2010). 819 IMPROVEMENT OF SURVIVAL IN A SWINE MODEL OF ACUTE LIVER FAILURE BY A NEW LIVER SUPPORT SYSTEM (HEPA WASH®). Journal of Hepatology. 52. S319–S320. 1 indexed citations
6.
Matevossian, Edouard, Aurel Perren, Zhonghua Yang, et al.. (2010). A Model of Ischemic Isolated Acute Liver Failure in Pigs: Standardizing Monitoring and Treatment. European Surgical Research. 45(2). 86–97. 3 indexed citations
8.
Kozik–Jaromin, Justyna, et al.. (2009). Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrology Dialysis Transplantation. 24(7). 2244–2251. 67 indexed citations
9.
Kreymann, Bernhard, et al.. (2009). Möglichkeiten und Zukunftsperspektiven der Leberersatztherapie. Intensivmedizin und Notfallmedizin. 46(5). 347–354.
10.
Umgelter, Andreas, Wolfgang Reindl, Jens Lutz, et al.. (2008). Treatment of Septic Patients with an Arginine-Based Endotoxin Adsorber Column Improves Hemodynamics and Reduces Oxidative Stress: Results of a Feasibility Study. Blood Purification. 26(4). 333–339. 5 indexed citations
11.
Huber, Wolfgang, Bernhard Kreymann, Michael Hennig, et al.. (2002). Haemodialysis for the Prevention of Contrast-Induced Nephropathy. Investigative Radiology. 37(9). 471–481. 21 indexed citations
12.
13.
Seige, Markus, et al.. (1999). Long term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplantation Proceedings. 31(1-2). 1371–1375. 46 indexed citations
15.
Kreymann, Bernhard, M. A. Ghatei, J. Domin, Sandip M. Kanse, & Stephen R. Bloom. (1991). Developmental Patterns of Glucagon-Like Peptide-1-(7–36) Amide and Peptide-YY in Rat Pancreas and Gut. Endocrinology. 129(2). 1001–1005. 21 indexed citations
16.
O’Halloran, Domhnall, George Nikou, Bernhard Kreymann, Mohammad A. Ghatei, & Stephen R. Bloom. (1990). Glucagon-like peptide-1 (7–36)-NH2: a physiological inhibitor of gastric acid secretion in man. Journal of Endocrinology. 126(1). 169–173. 75 indexed citations
17.
Kreymann, Bernhard, Mohammed A. Ghatei, Philip W. J. Burnet, et al.. (1989). Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus. Brain Research. 502(2). 325–331. 85 indexed citations
18.
Kanse, Sandip M., Bernhard Kreymann, Mohammad A. Ghatei, & Stephen R. Bloom. (1988). Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung. FEBS Letters. 241(1-2). 209–212. 97 indexed citations
19.
Kreymann, Bernhard, Y. Yiangou, Sandip M. Kanse, et al.. (1988). Isolation and characterisation of GLP‐1 7–36 amide from rat intestine Elevated levels in diabetic rats. FEBS Letters. 242(1). 167–170. 34 indexed citations
20.
Kreymann, Bernhard, Mohammad A. Ghatei, Gareth Williams, & Stephen R. Bloom. (1987). GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN. The Lancet. 330(8571). 1300–1304. 1566 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026